(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PEFAKIT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PEFAKIT

ST13

US500000079091943

Class

1, 5

Filing

79091943

Registration

4107292

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

47

Latest update

12/26/2025

Trademark type

Word

Nice classes

1, 5

Filing date

09/17/2010

Registration date

03/06/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/08/2022

Last transaction

12/26/2025

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

CH

Examiner

FINNEGAN, TIMOTHY

Law office

L40

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Pentapharm AG
DSM IP Assets B.V.
DSM IP Assets B.V.

Representatives

DUANE M. BYERS NIXON & VANDERHYE P.C.

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical preparations for pharmaceutical or medical purposesfor the detection of fibrinogen polymerization disordersdetermination of initial thrombin formation by intrinsic activationdetermination of factor Xa and factor lla inhibitors and determination of resistance of Factor Va to inactivation by activated protein CAPCcaused by the factor V Leiden mutationFV: Q506; diagnostic preparations for medical purposes

Class 5

Chemical preparations for pharmaceutical or medical purposesfor the detection of fibrinogen polymerization disordersdetermination of initial thrombin formation by intrinsic activationdetermination of factor Xa and factor lla inhibitors and determination of resistance of Factor Va to inactivation by activated protein C (APC) caused by the factor V Leiden mutation (FV:Q506); diagnostic preparations for medical purposes

Publications

History of USPTO decisions and trademark events.

47 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/25/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/15/2024

CHLD

CHANGE OF OWNER RECEIVED FROM IB

01/07/2023

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

08/08/2022

71AG

REGISTERED-SEC.71 ACCEPTED

08/08/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/02/2022

ES71

TEAS SECTION 71 RECEIVED

02/25/2022

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

03/06/2021

RNWL

INTERNATIONAL REGISTRATION RENEWED

05/30/2019

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

03/12/2018

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

03/12/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/12/2018

ES75

TEAS SECTION 71 & 15 RECEIVED

02/21/2018

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/19/2013

CORV

REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED

01/08/2013

MAIL

PAPER RECEIVED

12/17/2012

GPNX

NOTIFICATION PROCESSED BY IB

10/13/2012

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/24/2012

FIMP

FINAL DISPOSITION PROCESSED

09/24/2012

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/06/2012

R.PR

REGISTERED-PRINCIPAL REGISTER

03/06/2012

PUBO

PUBLISHED FOR OPPOSITION

12/20/2011

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/30/2011

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/30/2011

NPUB

NOTICE OF PUBLICATION

11/30/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/16/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/12/2011

CNEA

EXAMINERS AMENDMENT MAILED

11/07/2011

XAEC

EXAMINER'S AMENDMENT ENTERED

11/05/2011

ALIE

ASSIGNED TO LIE

11/04/2011

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/04/2011

CNFR

FINAL REFUSAL MAILED

09/06/2011

CNFR

FINAL REFUSAL WRITTEN

09/04/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/08/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/08/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/08/2011

PETG

PETITION TO REVIVE-GRANTED

08/08/2011

PROA

TEAS PETITION TO REVIVE RECEIVED

08/08/2011

RFNT

REFUSAL PROCESSED BY IB

02/19/2011

MAFR

APPLICATION FILING RECEIPT MAILED

02/05/2011

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/03/2011

RFRR

REFUSAL PROCESSED BY MPU

02/03/2011

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/03/2011

CNRT

NON-FINAL ACTION WRITTEN

02/02/2011

DOCK

ASSIGNED TO EXAMINER

02/01/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/01/2011

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

01/27/2011

Continuous trademark protection

Get notified about every new filing that threatens PEFAKIT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.